Leukoaraiosis

Leukoaraiosis is a condition often associated with aging and is characterized by the appearance of white matter changes in the brain. These changes are visible on brain imaging techniques such as MRI and CT scans. The term "leukoaraiosis" is derived from the Greek words "leuko" meaning white, and "araiosis" meaning rarefaction.

Causes

The exact cause of leukoaraiosis is not known. However, it is believed to be related to ischemia or lack of blood flow to the small blood vessels of the brain. Other factors that may contribute to the development of leukoaraiosis include hypertension, diabetes, and smoking.

Symptoms

Leukoaraiosis is often asymptomatic, meaning it does not cause any symptoms. However, in some cases, it may lead to cognitive decline, dementia, stroke, and gait disturbances.

Diagnosis

Leukoaraiosis is typically diagnosed through brain imaging techniques such as MRI or CT scans. These scans can reveal the characteristic white matter changes associated with the condition.

Treatment

There is currently no specific treatment for leukoaraiosis. Management of the condition primarily involves controlling risk factors such as hypertension, diabetes, and smoking. In some cases, medications may be used to manage symptoms.

Prognosis

The prognosis for individuals with leukoaraiosis varies. Some individuals may remain asymptomatic, while others may experience cognitive decline, dementia, stroke, or gait disturbances.

See also

• Magnetic Resonance Imaging
• Computed Tomography
• Ischemia
• Hypertension
• Diabetes
• Smoking
• Dementia
• Stroke
• Gait disturbances

• 
  Leukoaraiosis
• 
  Leukoaraiosis
• 
  Periventricular white matter lesions (annotated)
• 
  Normal pressure hydrocephalus versus atrophy